This cohort study assesses the incidence of cancer-associated venous thromboemoblism (VTE) among patients in the Department of Veterans Affairs health care system with solid and hematologic neoplasms and analyzes the patient-specific, cancer-specific, and treatment-specific factors associated with the risk of VTE.